Similar articles for PMID: 19411068

Year	Number of Results
1998	1
2000	3
2001	2
2003	2
2004	2
2005	2
2006	6
2007	8
2008	9
2009	9
2010	2
2011	5
2012	7
2013	10
2014	9
2015	8
2016	5
2017	6
2018	5
2019	5
2020	4
2021	3
2022	1
2024	0

1

CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis.

Pei XH, Bai F, Smith MD, Usary J, Fan C, Pai SY, Ho IC, Perou CM, Xiong Y. Pei XH, et al. Cancer Cell. 2009 May 5;15(5):389-401. doi: 10.1016/j.ccr.2009.03.004. Cancer Cell. 2009. PMID: 19411068 Free PMC article.

2

Loss of function of GATA3 induces basal-like mammary tumors.

Bai F, Zheng C, Liu X, Chan HL, Liu S, Ma J, Ren S, Zhu WG, Pei XH. Bai F, et al. Theranostics. 2022 Jan 1;12(2):720-733. doi: 10.7150/thno.65796. eCollection 2022. Theranostics. 2022. PMID: 34976209 Free PMC article.

3

Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation.

Bai F, Smith MD, Chan HL, Pei XH. Bai F, et al. Oncogene. 2013 May 30;32(22):2715-25. doi: 10.1038/onc.2012.293. Epub 2012 Jul 9. Oncogene. 2013. PMID: 22777348

4

GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer.

Bai F, Zhang LH, Liu X, Wang C, Zheng C, Sun J, Li M, Zhu WG, Pei XH. Bai F, et al. Theranostics. 2021 Jul 13;11(17):8218-8233. doi: 10.7150/thno.59280. eCollection 2021. Theranostics. 2021. PMID: 34373738 Free PMC article.

5

Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.

Wang C, Bai F, Zhang LH, Scott A, Li E, Pei XH. Wang C, et al. Breast Cancer Res. 2018 Jul 11;20(1):74. doi: 10.1186/s13058-018-0996-9. Breast Cancer Res. 2018. PMID: 29996906 Free PMC article.

6

Erythroid Kruppel-like factor regulates the G1 cyclin dependent kinase inhibitor p18INK4c.

Tallack MR, Keys JR, Perkins AC. Tallack MR, et al. J Mol Biol. 2007 Jun 1;369(2):313-21. doi: 10.1016/j.jmb.2007.02.109. Epub 2007 Mar 20. J Mol Biol. 2007. PMID: 17442339

7

Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.

Asselin-Labat ML, Sutherland KD, Vaillant F, Gyorki DE, Wu D, Holroyd S, Breslin K, Ward T, Shi W, Bath ML, Deb S, Fox SB, Smyth GK, Lindeman GJ, Visvader JE. Asselin-Labat ML, et al. Mol Cell Biol. 2011 Nov;31(22):4609-22. doi: 10.1128/MCB.05766-11. Epub 2011 Sep 19. Mol Cell Biol. 2011. PMID: 21930782 Free PMC article.

8

Gata3 restrains B cell proliferation and cooperates with p18INK4c to repress B cell lymphomagenesis.

Liu S, Chan HL, Bai F, Ma J, Scott A, Robbins DJ, Capobianco AJ, Zhu P, Pei XH. Liu S, et al. Oncotarget. 2016 Sep 27;7(39):64007-64020. doi: 10.18632/oncotarget.11746. Oncotarget. 2016. PMID: 27588406 Free PMC article.

9

Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues.

Ramsey MR, Krishnamurthy J, Pei XH, Torrice C, Lin W, Carrasco DR, Ligon KL, Xiong Y, Sharpless NE. Ramsey MR, et al. Cancer Res. 2007 May 15;67(10):4732-41. doi: 10.1158/0008-5472.CAN-06-3437. Cancer Res. 2007. PMID: 17510401

10

C1orf106, an innate immunity activator, is amplified in breast cancer and is required for basal-like/luminal progenitor fate decision.

Ma J, Liu C, Yang D, Song J, Zhang J, Wang T, Wang M, Xu W, Li X, Ding S, Zhan J, Zhang H. Ma J, et al. Sci China Life Sci. 2019 Sep;62(9):1229-1242. doi: 10.1007/s11427-019-9570-y. Epub 2019 Aug 1. Sci China Life Sci. 2019. PMID: 31376015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

102 results

Results by year